Key result
DES successfully seals an aneurysmal false lumen in SCAD with no restenosis at 2 years.
Why the study?
There is no established strategy for the management of coronary aneurysm or progression of aneurysmal false lumen in spontaneous coronary artery dissection.
Does a second-generation drug-eluting stent heal aneurysmal false lumen in a patient with spontaneous coronary artery dissection?
Case Report (n=1)
No
Does a second-generation drug-eluting stent heal aneurysmal false lumen in a patient with spontaneous coronary artery dissection?
Implantation of a second-generation drug-eluting stent successfully sealed an aneurysmal false lumen in a patient with spontaneous coronary artery dissection, suggesting it as a viable therapeutic option.
Answers are grounded in this paper and cite their sources.
May support DES use in select SCAD cases with false lumen aneurysm; leaves open need for prospective validation.
BACKGROUND: According to 2023 ESC Guideline, conservative medical management is generally recommended for the treatment of spontaneous coronary artery dissection (SCAD) except for patients with signs of ongoing myocardial ischemia. However, in some cases, invasive treatment (coronary artery bypass graft surgery or percutaneous coronary intervention (PCI)) is performed because of the progression of aneurysm in SCAD. Although there is no established strategy for the management of coronary aneurysm in SCAD, we report a case of successful healing of aneurysmal false lumen (AFL) using a second-generation drug-eluting stent (DES) in SCAD. CASE PRESENTATION: A 44-year-old woman without any cardiovascular risk factors was transferred to our hospital due to inferior myocardial infarction. Coronary angiography (CAG) showed multiple SCADs in the coronary artery. We performed PCI to the distal right coronary artery (RCA) because the RCA showed severe stenosis (99%) with bradycardia. Six days after the first PCI, SCAD relapsed in the mid left anterior descending artery (LAD). Furthermore, AFL was observed by intravascular ultrasound imaging. To avoid enlargement of the AFL and progression of the dissection toward the proximal site of the LAD, we performed PCI to the mid LAD to seal the entry tear of the dissection using a second-generation DES. CAG revealed that the AFL in the mid LAD completely diminished at 1 year after PCI. CONCLUSIONS: The implantation of a second-generation DES might be one of therapeutic options for sealing AFL in SCAD patients.
No takes yet. Share an insight, caveat, or question.
Niida et al. (2024) conducted a case report in Spontaneous coronary artery dissection (SCAD) with aneurysmal false lumen (n=1). Second-generation drug-eluting stent (DES) was evaluated on Healing of aneurysmal false lumen. Implantation of a second-generation drug-eluting stent successfully sealed an aneurysmal false lumen in a patient with spontaneous coronary artery dissection, with no restenosis at 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: